Fig. 1: Genomic characterization of S/R RCC reveals distinctive genomic features.
From: Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

a Overview of the clinical, molecular, and cell line data. (b) Comparison of S/R vs. non-S/R RCC by mutations & indels, deletions, and amplifications in the CheckMate, OncoPanel, and TCGA cohorts. *q < 0.05 (Fisher’s method meta-analysis of Fisher’s two-sided exact tests); ICI: Immune Checkpoint Inhibitor; IF: Immunofluorescence; IHC: Immunohistochemistry; RNA-seq: RNA-sequencing; S/R: Sarcomatoid/Rhabdoid; TCGA: The Cancer Genome Atlas; WES: Whole Exome Sequencing.